Skip to Content
Find More Like This
Return to Search

Methods of treating Parkinson's disease using viral vectors

United States Patent

November 13, 2012
View the Complete Patent at the US Patent & Trademark Office
Lawrence Berkeley National Laboratory - Visit the Technology Transfer and Intellectual Property Management Department Website
Methods of delivering viral vectors, particularly recombinant AAV virions, to the central nervous system (CNS) are provided for the treatment of CNS disorders, particularly those disorders which involve the neurotransmitter dopamine. The methods entail providing rAAV virions that comprise a transgene encoding aromatic amino acid decarboxylase (AADC) and administering the virions to the brain of a mammal using a non-manual pump.
Bankiewicz; Krys (Garrett Park, MD), Cunningham; Janet (Alameda, CA)
Genzyme Corporation (Framingham, MA), The Regents of the University of California (Oakland, CA)
12/ 384,935
April 10, 2009
REFERENCE TO GOVERNMENT RIGHTS Part of this work was made under the auspices of the U.S. Department of Energy, at the University of California/Lawrence Berkeley National Laboratory, under CRADA No. BG98039 and DOE Contract No. DE-AC03-76SF00098, now Contract No. DE-AC02-05CH11231. The government has certain rights in this invention.